Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Mar 14

PMID 30862050

Citations 73

Authors

Said M Afify

Masaharu Seno

Affiliations

Soon will be listed here.

Abstract

Cancer stem cells (CSCs) also known as cancer-initiating cells (CIC), are responsible for the sustained and uncontrolled growth of malignant tumors and are proposed to play significant roles in metastasis and recurrence. Several hypotheses have proposed that the events in either stem and/or differentiated cells, such as genomic instability, inflammatory microenvironment, cell fusion, and lateral gene transfer, should be considered as the possible origin of CSCs. However, until now, the exact origin of CSC has been obscure. The development of induced pluripotent stem cells (iPSCs) in 2007, by Yamanaka's group, has been met with much fervency and hailed as a breakthrough discovery by the scientific and research communities, especially in regeneration therapy. The studies on the development of CSC from iPSCs should also open a new page of cancer research, which will help in designing new therapies applicable to CSCs. Currently most reviews have focused on CSCs and CSC niches. However, the insight into the niche before the CSC niche should also be of keen interest. This review introduces the novel concept of cancer initiation introducing the conversion of iPSCs to CSCs and proposes a relationship between the inflammatory microenvironment and cancer initiation as the key concept of the cancer-inducing niche responsible for the development of CSC.

Citing Articles

Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK/MAPK Signaling Cascades.

Song Y, Kim J, Rajbongshi L, Lim Y, Ok Y, Hwang S Int J Mol Sci. 2025; 26(1.

PMID: 39796130 PMC: 11720593. DOI: 10.3390/ijms26010274.

TNF-α-Induced NF-κB Alter the Methylation Status of Some Stemness Genes in HT-29 Human Colon Cancer Cell.

Zand H, Hosseini S, Cheraghpour M, Alipour M, Sedaghat F Adv Biomed Res. 2024; 13:114.

PMID: 39717245 PMC: 11665177. DOI: 10.4103/abr.abr_75_24.

Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights.

Shah D, Chorawala M, Pandya A, Kothari N, Prajapati B, Parekh P Curr Med Sci. 2024; 44(6):1155-1174.

PMID: 39676146 DOI: 10.1007/s11596-024-2936-5.

The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.

Masciale V, Banchelli F, Grisendi G, Samarelli A, Raineri G, Rossi T J Biol Chem. 2024; 300(12):107994.

PMID: 39547513 PMC: 11714729. DOI: 10.1016/j.jbc.2024.107994.

Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.

Khan S, Alson D, Sun L, Maloney C, Sun D Cancers (Basel). 2024; 16(21).

PMID: 39518076 PMC: 11545784. DOI: 10.3390/cancers16213639.

References

Baylin S, Jones P . Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol. 2016; 8(9). PMC: 5008069. DOI: 10.1101/cshperspect.a019505. View

Vaux D . In defense of the somatic mutation theory of cancer. Bioessays. 2011; 33(5):341-3. DOI: 10.1002/bies.201100022. View

Moore K, Lemischka I . Stem cells and their niches. Science. 2006; 311(5769):1880-5. DOI: 10.1126/science.1110542. View

Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View

Versteeg R . Cancer: Tumours outside the mutation box. Nature. 2014; 506(7489):438-9. DOI: 10.1038/nature13061. View

Thorpe L, Yuzugullu H, Zhao J . PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer. 2014; 15(1):7-24. PMC: 4384662. DOI: 10.1038/nrc3860. View

Oskarsson T, Batlle E, Massague J . Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014; 14(3):306-21. PMC: 3998185. DOI: 10.1016/j.stem.2014.02.002. View

Shime H, Yabu M, Akazawa T, Kodama K, Matsumoto M, Seya T . Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol. 2008; 180(11):7175-83. DOI: 10.4049/jimmunol.180.11.7175. View

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

10.

Nair N, Sanchez Calle A, Zahra M, Prieto-Vila M, Oo A, Hurley L . A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci Rep. 2017; 7(1):6838. PMC: 5533745. DOI: 10.1038/s41598-017-07144-5. View

11.

Mountford J . Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. Transfus Med. 2008; 18(1):1-12. DOI: 10.1111/j.1365-3148.2007.00807.x. View

12.

Inaba M, Yamashita Y . Asymmetric stem cell division: precision for robustness. Cell Stem Cell. 2012; 11(4):461-9. DOI: 10.1016/j.stem.2012.09.003. View

13.

Sell S . On the stem cell origin of cancer. Am J Pathol. 2010; 176(6):2584-494. PMC: 2877820. DOI: 10.2353/ajpath.2010.091064. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Jacqueline C, Biro P, Beckmann C, Moller A, Renaud F, Sorci G . Cancer: A disease at the crossroads of trade-offs. Evol Appl. 2017; 10(3):215-225. PMC: 5322410. DOI: 10.1111/eva.12444. View

16.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J . Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6):7204-7218. PMC: 5805548. DOI: 10.18632/oncotarget.23208. View

17.

Ciccarelli F . Mutations differ in normal and cancer cells of the oesophagus. Nature. 2019; 565(7739):301-303. DOI: 10.1038/d41586-018-07737-8. View

18.

Bayarsaihan D . Epigenetic mechanisms in inflammation. J Dent Res. 2010; 90(1):9-17. PMC: 3144097. DOI: 10.1177/0022034510378683. View

19.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

20.

Sanchez Calle A, Nair N, Oo A, Prieto-Vila M, Koga M, Khayrani A . A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm). Am J Cancer Res. 2017; 6(12):2799-2815. PMC: 5199755. View